(Australia-NewsWire.Com, February 12, 2018 ) Injectable drug delivery is characterized as introduction of a drug or drugs in the patient by utilizing a delivery device. Injectables permit the transport of drug in fluid form, directly into the body.According to the report Asia Pacific Injectable Drug Delivery Market, published by Market Data Forecast, the Market was worth USD 83.35 billion in 2016 and estimated to be growing at a CAGR of 12.15%, to reach 147.87 billion by 2021
The key factors driving the development of injectables are increase in the cases of cancer and diabetic patients, enhanced patient consistence to drug delivery system and advancement in technology. The key limiting factors that affect the development of injectables market incorporate injuries caused while administering injectables, patient safety issues, advancement of substitute drug delivery methods and product reviews.
Injectable Drug Delivery Market is segmented into Device Type, Formulation, Therapeutic Use, End-user Application, Region. On the basis of Device type, the market is segmented into Self-Injection Devices, Conventional Devices. On the basis of Formulation, the market is segmented into Conventional Drug Delivery, Novel Drug Delivery. On the basis of Therapeutic Use, market is divided into Autoimmune Disorders, Hormonal Disorders, Oncology. On the basis of end user application, the market is further divided into Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories.
On the basis of geography, the Asia-Pacific market is analyzed under various regions namely Japan, China, Australia, India and South Korea. The developing Asian and Latin America nations collectively represent to the fastest developing business sector for injectables because of the increase in occurrences of disease and diabetes in patients and furthermore their consistence to novel advancements. Besides, the drug and device manufacturers are concentrating on major rising injectables market of Asia and Asia-Pacific because of less stringent directions for obtaining approvals on less competition and devices.
Some of the major companies dominating the market, by their products and services include Antares Pharmaceuticals Ltd, Baxter International, Becton Dickinson Company, Elcam Medical, Eli Lily and Company, Unilife Corporation and West Pharmaceutical Inc.
The scope of the report provides:
The evaluation of the current market for your product or services and the future implications of the market
Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porterís Five Forces
The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
Equip you with the information providing with the investment opportunities in the industry
About Market Data Forecast
Being a familiar face to the Fortune 500 companies in the field of market research, Market Data Forecast provides its clientele with research material through syndicated reports, consult projects and industry newsletters across various domains and verticals. Our in-house research panel, comprises of industry experts, vertical/domain specialists, supported by a well-built research & data models that help in providing insights for making well-informed decisions. We have a well-established data gathering network across 100+ countries through tie-ups and collaborationís with the key personnel in value chains & local research organizations. Apart the excellent research services, we also boast of unique post-purchase services offering a 24*7 analyst support for the period of six months. Further, though a continuous feedback from our users, clients and experts, we keep on innovating ourselves in this field to support the organizations in the most efficient ways.